These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 19103993)

  • 21. FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT.
    Zhang X; Hu C; Kong CY; Song P; Wu HM; Xu SC; Yuan YP; Deng W; Ma ZG; Tang QZ
    Cell Death Differ; 2020 Feb; 27(2):540-555. PubMed ID: 31209361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ERKs/p53 signal transduction pathway is involved in doxorubicin-induced apoptosis in H9c2 cells and cardiomyocytes.
    Liu J; Mao W; Ding B; Liang CS
    Am J Physiol Heart Circ Physiol; 2008 Nov; 295(5):H1956-65. PubMed ID: 18775851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HMGB1 contributes to adriamycin-induced cardiotoxicity via up-regulating autophagy.
    Luo P; Zhu Y; Chen M; Yan H; Yang B; Yang X; He Q
    Toxicol Lett; 2018 Aug; 292():115-122. PubMed ID: 29715512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GATA4-targeted compound exhibits cardioprotective actions against doxorubicin-induced toxicity in vitro and in vivo: establishment of a chronic cardiotoxicity model using human iPSC-derived cardiomyocytes.
    Karhu ST; Kinnunen SM; Tölli M; Välimäki MJ; Szabó Z; Talman V; Ruskoaho H
    Arch Toxicol; 2020 Jun; 94(6):2113-2130. PubMed ID: 32185414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diverging effects of enalapril or eplerenone in primary prevention against doxorubicin-induced cardiotoxicity.
    Hullin R; Métrich M; Sarre A; Basquin D; Maillard M; Regamey J; Martin D
    Cardiovasc Res; 2018 Feb; 114(2):272-281. PubMed ID: 29016737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spironolactone Attenuates Doxorubicin-induced Cardiotoxicity in Rats.
    Liu G; Liu Y; Wang R; Hou T; Chen C; Zheng S; Dong Z
    Cardiovasc Ther; 2016 Aug; 34(4):216-24. PubMed ID: 27097055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resveratrol attenuates doxorubicin-induced cardiomyocyte apoptosis in mice through SIRT1-mediated deacetylation of p53.
    Zhang C; Feng Y; Qu S; Wei X; Zhu H; Luo Q; Liu M; Chen G; Xiao X
    Cardiovasc Res; 2011 Jun; 90(3):538-45. PubMed ID: 21278141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pifithrin-alpha protects against doxorubicin-induced apoptosis and acute cardiotoxicity in mice.
    Liu X; Chua CC; Gao J; Chen Z; Landy CL; Hamdy R; Chua BH
    Am J Physiol Heart Circ Physiol; 2004 Mar; 286(3):H933-9. PubMed ID: 14766674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting excessive autophagy through AMPK and p38-MAPK.
    Wang X; Wang XL; Chen HL; Wu D; Chen JX; Wang XX; Li RL; He JH; Mo L; Cen X; Wei YQ; Jiang W
    Biochem Pharmacol; 2014 Apr; 88(3):334-50. PubMed ID: 24522112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HSP25 down-regulation enhanced p53 acetylation by dissociation of SIRT1 from p53 in doxorubicin-induced H9c2 cell apoptosis.
    Zhang C; Qu S; Wei X; Feng Y; Zhu H; Deng J; Wang K; Liu K; Liu M; Zhang H; Xiao X
    Cell Stress Chaperones; 2016 Mar; 21(2):251-60. PubMed ID: 26515559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HDL protects against doxorubicin-induced cardiotoxicity in a scavenger receptor class B type 1-, PI3K-, and Akt-dependent manner.
    Durham KK; Chathely KM; Mak KC; Momen A; Thomas CT; Zhao YY; MacDonald ME; Curtis JM; Husain M; Trigatti BL
    Am J Physiol Heart Circ Physiol; 2018 Jan; 314(1):H31-H44. PubMed ID: 28986362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment with apolipoprotein A1 protects mice against doxorubicin-induced cardiotoxicity in a scavenger receptor class B, type I-dependent manner.
    Durham KK; Kluck G; Mak KC; Deng YD; Trigatti BL
    Am J Physiol Heart Circ Physiol; 2019 Jun; 316(6):H1447-H1457. PubMed ID: 31002281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dihydromyricetin prevents cardiotoxicity and enhances anticancer activity induced by adriamycin.
    Zhu H; Luo P; Fu Y; Wang J; Dai J; Shao J; Yang X; Chang L; Weng Q; Yang B; He Q
    Oncotarget; 2015 Feb; 6(5):3254-67. PubMed ID: 25226612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Triptolide dysregulates glucose uptake via inhibition of IKKβ-NF-κB pathway by p53 activation in cardiomyocytes.
    Xi Y; Zhang Y; Pan J; Chen S; Lu S; Shen F; Huang Z
    Toxicol Lett; 2020 Jan; 318():1-11. PubMed ID: 31618665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective effect of taurine against doxorubicin-induced cardiotoxicity in rats: echocardiographical and histological findings.
    Barış VÖ; Gedikli E; Yersal N; Müftüoğlu S; Erdem A
    Amino Acids; 2019 Nov; 51(10-12):1649-1655. PubMed ID: 31673792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of doxorubicin-induced cardiac dysfunction in dominant-negative p38α mitogen-activated protein kinase mice.
    Thandavarayan RA; Watanabe K; Sari FR; Ma M; Lakshmanan AP; Giridharan VV; Gurusamy N; Nishida H; Konishi T; Zhang S; Muslin AJ; Kodama M; Aizawa Y
    Free Radic Biol Med; 2010 Nov; 49(9):1422-31. PubMed ID: 20705132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress.
    Zhao D; Xue C; Li J; Feng K; Zeng P; Chen Y; Duan Y; Zhang S; Li X; Han J; Yang X
    Biochem Biophys Res Commun; 2020 Dec; 533(3):304-312. PubMed ID: 32958254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of Mrp1 Potentiates Doxorubicin-Induced Cytotoxicity in Neonatal Mouse Cardiomyocytes and Cardiac Fibroblasts.
    Zhang W; St Clair D; Butterfield A; Vore M
    Toxicol Sci; 2016 May; 151(1):44-56. PubMed ID: 26822305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased Soluble Guanylate Cyclase Contributes to Cardiac Dysfunction Induced by Chronic Doxorubicin Treatment in Mice.
    Vandenwijngaert S; Swinnen M; Walravens AS; Beerens M; Gillijns H; Caluwé E; Tainsh RE; Nathan DI; Allen K; Brouckaert P; Bartunek J; Scherrer-Crosbie M; Bloch KD; Bloch DB; Janssens SP; Buys ES
    Antioxid Redox Signal; 2017 Feb; 26(4):153-164. PubMed ID: 27505125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Baicalein alleviates doxorubicin-induced cardiotoxicity via suppression of myocardial oxidative stress and apoptosis in mice.
    Sahu BD; Kumar JM; Kuncha M; Borkar RM; Srinivas R; Sistla R
    Life Sci; 2016 Jan; 144():8-18. PubMed ID: 26606860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.